[1]
Bhardwaj, A. and Mukherjee, S. 2022. Carcinogen tainted generic drugs: a matter of concern. International Journal of Basic & Clinical Pharmacology. 11, 3 (Apr. 2022), 294–295. DOI:https://doi.org/10.18203/2319-2003.ijbcp20221050.